TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

TFA Therapeutics (RAJAF) EBITDA (2022 - 2023)

Updated

TFA Therapeutics' EBITDA came in at $68,132 for FY2025, down 71.6% from $240,145 in FY2024.

Analysis

TFA Therapeutics (RAJAF) EBITDA (2022 - 2023) Analysis & Trends

Going back to FY2020, TFA Therapeutics' EBITDA data covers 6 years.

  • EBITDA carries a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
  • The FY2025 figure represents the lowest annual EBITDA since FY2022.
  • Per Business Quant, earlier years put EBITDA at $240,145 in FY2024 (-35.2%), $370,806 in FY2023, -$333,965 in FY2022 and $34,783 in FY2021 (-1.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Procter & Gamble 390.78 Bn 342.58 Bn 11.60 Bn 6.75 Bn
2 Colgate Palmolive 77.96 Bn 72.79 Bn 3.23 Bn 1.25 Bn
3 Estee Lauder Companies 41.21 Bn 28.31 Bn 2.81 Bn 599.00 Mn
4 Kenvue 37.02 Bn 32.73 Bn 2.31 Bn 849.00 Mn
5 Kimberly Clark 36.84 Bn 32.92 Bn 1.44 Bn 700.00 Mn
6 Church & Dwight 26.38 Bn 24.77 Bn 749.40 Mn 468.20 Mn
7 Clorox 12.88 Bn 11.29 Bn 770.00 Mn 525.00 Mn
8 e.l.f. Beauty 7.00 Bn 5.82 Bn 370.22 Mn 76.96 Mn
9 Reynolds Consumer Products 5.26 Bn 4.95 Bn 236.00 Mn 131.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 176,165.00
Dec 31, 2022 -24,656.00
API Access

TFA Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RAJAF&period=max&api_key=YOUR_API_KEY